# EDGAR Filing Document

**Accession Number:** 0001708527
**File Stem:** 0001558370-25-008401
**Filing Date:** 2025-6
**Character Count:** 5671
**Document Hash:** 311c796b937b2ae4407b1747b2073441
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001558370-25-008401.hdr.sgml**: 20250604

**ACCESSION NUMBER**: 0001558370-25-008401

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20250529

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20250604

**DATE AS OF CHANGE**: 20250604

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ELUTIA INC.
- **CENTRAL INDEX KEY:** 0001708527
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 474790334
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39577
- **FILM NUMBER:** 251023915

**BUSINESS ADDRESS:**
- **STREET 1:** 12510 PROSPERITY DRIVE
- **STREET 2:** SUITE 370
- **CITY:** SILVER SPRING
- **STATE:** MD
- **ZIP:** 20904
- **BUSINESS PHONE:** 240-247-1143

**MAIL ADDRESS:**
- **STREET 1:** 12510 PROSPERITY DRIVE
- **STREET 2:** SUITE 370
- **CITY:** SILVER SPRING
- **STATE:** MD
- **ZIP:** 20904

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AZIYO BIOLOGICS, INC.
- **DATE OF NAME CHANGE:** 20170605

?xml version='1.0' encoding='ASCII'?

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

**Date of report (Date of earliest event reported): May 29, 2025**

## ELUTIA INC.
**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-39577** | **47-4790334** |
| **(State or other jurisdictionof incorporation)** | **(CommissionFile Number)** | **(I.R.S. EmployerIdentification No.)** |

---

**20 Firstfield Road** 

**Gaithersburg, MD 20878**

**(Address of principal executive offices) (Zip Code)**

**(240) 247-1170**

**(Registrant's telephone number, include area code)**

**N/A**

**(Former name or former address, if changed since last report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbols** | **Name of each exchangeon which registered** |
| Class A Common Stock, $0.001 par value per share | ELUT | The Nasdaq Capital Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 5.07** | **Submission of Matters to a Vote of Security Holders.** |

---

On May 29, 2025, Elutia Inc. (the "Company") held its annual meeting of stockholders. A total of 29,585,703 shares of the Company's Class A common stock were present in person or represented by proxy at the meeting, representing approximately 80.9% of the Company's Class A common stock outstanding as of the April 1, 2025 record date. The voting results for the proposals considered and voted upon at the meeting, each of which were described in the Company's proxy statement, are as follows:

Proposal 1 – Election of two Class II directors to hold office until the Company's annual meeting of stockholders to be held in 2028 and until their respective successors have been duly elected and qualified.

---

| | | | |
|:---|:---|:---|:---|
|  | &nbsp;&nbsp;**Votes**<br>**FOR** | &nbsp;&nbsp;**Votes**<br>**WITHHELD** | &nbsp;&nbsp;**Broker**<br>**Non-Votes** |
| &nbsp;&nbsp;Brigid A. Makes | &nbsp;&nbsp;19152084 | &nbsp;&nbsp;5806525 | &nbsp;&nbsp;4627094 |
| &nbsp;&nbsp;C. Randal Mills, Ph.D. | &nbsp;&nbsp;21801664 | &nbsp;&nbsp;3156945 | &nbsp;&nbsp;4627094 |

---

Accordingly, the nominees for Class II directors were elected.

Proposal 2 – Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**Votes**<br>**FOR** | &nbsp;&nbsp;**Votes**<br>**AGAINST** | &nbsp;&nbsp;**Votes**<br>**ABSTAINED** | &nbsp;&nbsp;**Broker**<br>**Non-Votes** |
| &nbsp;&nbsp;29581065 | &nbsp;&nbsp;4458 | &nbsp;&nbsp;180 | &nbsp;&nbsp;- |

---

Accordingly, the Company's stockholders approved Proposal 2 set forth above.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | ELUTIA INC. | ELUTIA INC. |
| Date: June 4, 2025 | By: | /s/ Matthew Ferguson |
|  |  | Matthew Ferguson |
|  |  | Chief Financial Officer |

---